CLINICAL_TRIALS
research
· 2024-08-07
Clinical Trial Update: Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy [NA]
Summary
An update on a clinical trial evaluating the Minimally Invasive Micro Sclerostomy (MIMS) procedure to reduce intraocular pressure in primary open-angle glaucoma…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Sanoculis Ltd | Conditions: Primary Open Angle Glaucoma, Open Angle Glaucoma | NA | Status: RECRUITING